EP 1311505 A2 20030521 - QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE ( NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS )
Title (en)
QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE ( NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS )
Title (de)
MIT HETEROARYL GRUPPEN SUBSTITUIERTE CHINUKLIDINE ZUR BEHANDLUNG VON KRANKHEITEN ( NIKOTIN ACETYLCHOLIN REZEPTOR LIGANDEN )
Title (fr)
FRAGMENTS HETEROARYLE A SUBSTITUTION QUINUCLIDINE DESTINES AU TRAITEMENT DE MALADIES
Publication
Application
Priority
- US 0122597 W 20010817
- US 22665200 P 20000821
- US 28483201 P 20010419
Abstract (en)
[origin: WO0216355A2] The invention provides compound of Formula (I): These compounds may be in the form of pharmaceutical salts or compositions, and racemic mixtures or pure enantiomers thereof. The compounds of Formula (I) are useful in pharmaceuticals in which alpha 7 is known to be involved.
IPC 1-7
IPC 8 full level
A61K 31/439 (2006.01); A61P 25/00 (2006.01); A61P 25/18 (2006.01); A61P 43/00 (2006.01); C07D 453/02 (2006.01)
CPC (source: EP)
A61P 25/00 (2017.12); A61P 25/18 (2017.12); A61P 43/00 (2017.12); C07D 453/02 (2013.01)
Citation (search report)
See references of WO 0216355A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0216355 A2 20020228; WO 0216355 A3 20020718; AU 8291001 A 20020304; EP 1311505 A2 20030521; JP 2004506734 A 20040304; PE 20020505 A1 20020612
DOCDB simple family (application)
US 0122597 W 20010817; AU 8291001 A 20010817; EP 01961664 A 20010817; JP 2002521456 A 20010817; PE 2001000834 A 20010821